Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination. (Q33395415)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Angelo Delmonte

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Filippo de Braud

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

T De Pas

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

G Rosati

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

G Spitaleri

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

C Boni

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

A Tucci

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

S Frustaci

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

R Scalamogna

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

D Radice

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

S Boselli

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

F Toffalorio

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

C Catania

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

C Noberasco

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

F Vecchio

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

18 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

57

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

217-224

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21597285%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Chemotherapy in adult soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

New medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Chemotherapy for metastatic soft tissue sarcomas – another full circle?

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Ifosfamide in the elderly: clinical considerations for a better drug management.

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Ifosfamide treatment as a 10-day continuous intravenous infusion

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Sample size tables for exact single-stage phase II designs

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Treatment of recurrent platinum-resistant ovarian cancer with pegylated liposomal doxorubicin--an evaluation of the therapeutic index with special emphasis on cardiac toxicity

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

High cumulative doses of pegylated liposomal doxorubicin are not associated with cardiac toxicity in patients with gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1159%2F000326466

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33395415&oldid=1961837159"